Literature DB >> 10441175

DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.

A Bengtsson1, R Nezlin, Y Shoenfeld, G Sturfelt.   

Abstract

The objective of this study was to investigate the relationship of DNA content in circulating immune complexes with disease course and activity in SLE. The DNA content in circulating immune complexes containing anti-DNA antibodies of IgG class was determined in serial samples from 28 patients with SLE by a quantitative immunochemical assay. The patients presented various active disease manifestations over 5-55 months. Disease activity (SLEDAI-score), drug treatment and ACR-criteria were recorded. Levels of anti-dsDNA, CRP, leukocytes, complement components C3, C4 and C1q were measured. Patients with severe flares and high SLEDAI scores had low Clq levels at onset of active disease manifestations. The patients with low C1q serum levels during flare (n=13) had significantly lower amounts of DNA in immune complexes than patients with normal Clq (P=0.001). Levels of DNA in immune complexes correlated with Clq at flares (r=0.62, P<0.0001) and correlated inversely with SLEDAI scores (r=-0.47, P=0.012). In conclusion, the low levels of DNA in circulating immune complexes found in severely ill SLE patients with concomitantly low serum concentrations of Clq prior to flares might be related to tissue deposition of immune complexes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441175     DOI: 10.1006/jaut.1999.0300

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  11 in total

1.  Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells.

Authors:  Myriam Martin; Jonatan Leffler; Anna M Blom
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

2.  Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.

Authors:  G S Alarcón; J Calvo-Alén; G McGwin; A G Uribe; S M A Toloza; J M Roseman; M Fernández; B J Fessler; L M Vilá; C Ahn; F K Tan; J D Reveille
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

3.  Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjögren's syndrome A antibodies.

Authors:  L Mathsson; E Ahlin; C Sjöwall; T Skogh; J Rönnelid
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

4.  C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC.

Authors:  S Xiao; C Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

5.  Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies.

Authors:  L A Trouw; M A Seelen; J M G J Duijs; H Benediktsson; C Van Kooten; M R Daha
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

Review 6.  Anti-DNA antibodies--quintessential biomarkers of SLE.

Authors:  David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2015-11-19       Impact factor: 20.543

7.  Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.

Authors:  Kristina N Ekdahl; Dan Norberg; Anders A Bengtsson; Gunnar Sturfelt; Ulf R Nilsson; Bo Nilsson
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

8.  C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation.

Authors:  Leendert A Trouw; Sara C Nilsson; Isabel Gonçalves; Göran Landberg; Anna M Blom
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

9.  Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.

Authors:  Anders A Bengtsson; Åsa Pettersson; Stina Wichert; Birgitta Gullstrand; Markus Hansson; Thomas Hellmark; Åsa C M Johansson
Journal:  Arthritis Res Ther       Date:  2014-06-05       Impact factor: 5.156

10.  Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use.

Authors:  Kerstin Sandholm; Barbro Persson; Lillemor Skattum; Gösta Eggertsen; Dag Nyman; Iva Gunnarsson; Elisabet Svenungson; Bo Nilsson; Kristina N Ekdahl
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.